[Form 3] Incyte Genomics Inc Initial Statement of Beneficial Ownership
Ramitpal K. Basi, serving as EVP, Human Resources of Incyte Corp (INCY), filed an initial Form 3 reporting the date triggering the filing as 08/25/2025. The filing states no securities are beneficially owned by the reporting person as of that date. The Form 3 shows the filing was executed on behalf of the reporting person by an attorney-in-fact, Elizabeth Feeney, with a signature date of 08/27/2025. This is a routine Section 16 initial ownership disclosure indicating the officer held no reportable shares or derivative positions at the event date.
- None.
- None.
FAQ
What did the Incyte (INCY) Form 3 filed by Ramitpal K. Basi report?
The Form 3 reported that no securities are beneficially owned by Ramitpal K. Basi as of the triggering date 08/25/2025.
What is Ramitpal K. Basi's role at Incyte reported on the Form 3?
The filing lists the reporting person as an Officer with the title EVP, Human Resources and indicates they are not a 10% owner or a director for this report.
Who signed the Form 3 for Ramitpal K. Basi and when?
The Form 3 was signed by Elizabeth Feeney, Attorney-In-Fact on 08/27/2025.
Does the Form 3 show any derivative or non-derivative holdings for INCY?
No. The filing explicitly states: No securities are beneficially owned, so there are no listed non-derivative or derivative holdings.
Why is a Form 3 filed and what does it indicate in this case?
A Form 3 is an initial Section 16 filing to disclose beneficial ownership by certain insiders; here it indicates the officer had no reportable holdings at the reported event date.